A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 232 participants.
Also called NCT04955990
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 232 participants
- Sponsor
- Registry
-
NCT04955990
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Argentina, Brazil, Canada, China, Germany, Italy, Japan, Malaysia, Netherlands, Poland, Puerto Rico, Singapore, South Korea, Spain, Sweden, United Kingdom
- Registry status
- Terminated
Technical summary
Registry record NCT04955990. Allocation not applicable; no masking; primary purpose other. Start 2021-10-14 (actual); primary completion 2022-12-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants
- Acronym
- CARE PAH
- Condition
- Pulmonary Arterial Hypertension
- Intervention (Other)
- PAH Therapies
- Lead sponsor
- Actelion
Record details
- Record id
cardio:ct-nct04955990- Content hash
8c4fb86995cc30701d252bad7cefbdf54f3501936e5c5977d3b0c58c851aa7fb